Antigenics to Report Earnings on February 19, 2004; Conference Call to Follow.Business Editors/Health/Medical Writers BIOWIRE2K NEW YORK--(BUSINESS WIRE)--Jan. 30, 2004 Antigenics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AGEN) will release its fourth quarter and full year 2003 financial results before the market opens on February February: see month. 19, 2004. Antigenics executives, including Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Garo Armen, PhD, and Senior Vice President of Development Renu Gupta, MD, will host a conference call at 11:00 a.m. ET that same day. To access the live call, dial 877.416.2362 (domestic) or 706.679.3850 (international); the access code is 5126017. The call will also be webcast and will be accessible from the company's website at www.antigenics.com/webcast/. A replay will be available approximately two hours after the call through midnight ET on March 4, 2004. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 5126017. The replay will also be available on the company's website approximately two hours after the live call. Antigenics is developing treatments for cancers, infectious diseases infectious diseases: see communicable diseases. and autoimmune disorders Autoimmune Disorders Definition Autoimmune disorders are conditions in which a person's immune system attacks the body's own cells, causing tissue destruction. . For more information about Antigenics, please visit www.antigenics.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion